The Conolidine Diaries
These final results, together with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 support the strategy of focusing on ACKR3 as a singular approach to modulate the opioid process, which could open new therapeutic avenues for opioid-similar Ailments.January three, 2024 Donating is